Literature DB >> 18436707

Neonatal diabetes mellitus.

Lydia Aguilar-Bryan1, Joseph Bryan.   

Abstract

An explosion of work over the last decade has produced insight into the multiple hereditary causes of a nonimmunological form of diabetes diagnosed most frequently within the first 6 months of life. These studies are providing increased understanding of genes involved in the entire chain of steps that control glucose homeostasis. Neonatal diabetes is now understood to arise from mutations in genes that play critical roles in the development of the pancreas, of beta-cell apoptosis and insulin processing, as well as the regulation of insulin release. For the basic researcher, this work is providing novel tools to explore fundamental molecular and cellular processes. For the clinician, these studies underscore the need to identify the genetic cause underlying each case. It is increasingly clear that the prognosis, therapeutic approach, and genetic counseling a physician provides must be tailored to a specific gene in order to provide the best medical care.

Entities:  

Mesh:

Year:  2008        PMID: 18436707      PMCID: PMC2528857          DOI: 10.1210/er.2007-0029

Source DB:  PubMed          Journal:  Endocr Rev        ISSN: 0163-769X            Impact factor:   19.871


  289 in total

1.  Molecular basis for K(ATP) assembly: transmembrane interactions mediate association of a K+ channel with an ABC transporter.

Authors:  B Schwappach; N Zerangue; Y N Jan; L Y Jan
Journal:  Neuron       Date:  2000-04       Impact factor: 17.173

2.  Enhancement of p53-dependent gene activation by the transcriptional coactivator Zac1.

Authors:  S M Huang; A H Schönthal; M R Stallcup
Journal:  Oncogene       Date:  2001-04-19       Impact factor: 9.867

Review 3.  Current status of the E23K Kir6.2 polymorphism: implications for type-2 diabetes.

Authors:  Michael J Riedel; Diana C Steckley; Peter E Light
Journal:  Hum Genet       Date:  2004-11-23       Impact factor: 4.132

4.  Serum glucagon counterregulatory hormonal response to hypoglycemia is blunted in congenital hyperinsulinism.

Authors:  Khalid Hussain; Joseph Bryan; Henrick T Christesen; Klaus Brusgaard; Lydia Aguilar-Bryan
Journal:  Diabetes       Date:  2005-10       Impact factor: 9.461

5.  New ABCC8 mutations in relapsing neonatal diabetes and clinical features.

Authors:  Martine Vaxillaire; Aurélie Dechaume; Kanetee Busiah; Hélène Cavé; Sabrina Pereira; Raphael Scharfmann; Guiomar Perez de Nanclares; Luis Castano; Philippe Froguel; Michel Polak
Journal:  Diabetes       Date:  2007-03-27       Impact factor: 9.461

6.  Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism.

Authors:  Valérie Senée; Claude Chelala; Sabine Duchatelet; Daorong Feng; Hervé Blanc; Jack-Christophe Cossec; Céline Charon; Marc Nicolino; Pascal Boileau; Douglas R Cavener; Pierre Bougnères; Doris Taha; Cécile Julier
Journal:  Nat Genet       Date:  2006-05-21       Impact factor: 38.330

7.  Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes.

Authors:  Anna L Gloyn; Ewan R Pearson; Jennifer F Antcliff; Peter Proks; G Jan Bruining; Annabelle S Slingerland; Neville Howard; Shubha Srinivasan; José M C L Silva; Janne Molnes; Emma L Edghill; Timothy M Frayling; I Karen Temple; Deborah Mackay; Julian P H Shield; Zdenek Sumnik; Adrian van Rhijn; Jerry K H Wales; Penelope Clark; Shaun Gorman; Javier Aisenberg; Sian Ellard; Pål R Njølstad; Frances M Ashcroft; Andrew T Hattersley
Journal:  N Engl J Med       Date:  2004-04-29       Impact factor: 91.245

8.  Proximal C-terminal domain of sulphonylurea receptor 2A interacts with pore-forming Kir6 subunits in KATP channels.

Authors:  Richard D Rainbow; Marian James; Diane Hudman; Mohammed Al Johi; Harprit Singh; Peter J Watson; Ian Ashmole; Noel W Davies; David Lodwick; Robert I Norman
Journal:  Biochem J       Date:  2004-04-01       Impact factor: 3.857

9.  The G53D mutation in Kir6.2 (KCNJ11) is associated with neonatal diabetes and motor dysfunction in adulthood that is improved with sulfonylurea therapy.

Authors:  Joseph C Koster; Francesco Cadario; Cinzia Peruzzi; Carlo Colombo; Colin G Nichols; Fabrizio Barbetti
Journal:  J Clin Endocrinol Metab       Date:  2007-12-11       Impact factor: 5.958

10.  Transient neonatal diabetes mellitus is associated with a recurrent (R201H) KCNJ11 (KIR6.2) mutation.

Authors:  C Colombo; M Delvecchio; C Zecchino; M F Faienza; L Cavallo; F Barbetti
Journal:  Diabetologia       Date:  2005-10-05       Impact factor: 10.122

View more
  83 in total

1.  Mutations in G6PC2 do not contribute to monogenic forms of early infancy diabetes and beta cell dysfunction.

Authors:  A Bonnefond; N Bouatia-Naji; A Simon; C Saint-Martin; A Dechaume; P de Lonlay; M Polak; C Bellanné-Chantelot; P Froguel; M Vaxillaire
Journal:  Diabetologia       Date:  2009-02-24       Impact factor: 10.122

Review 2.  Imprinted Zac1 in neural stem cells.

Authors:  Guillaume Daniel; Udo Schmidt-Edelkraut; Dietmar Spengler; Anke Hoffmann
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

3.  Insulin secretion and Ca2+ dynamics in β-cells are regulated by PERK (EIF2AK3) in concert with calcineurin.

Authors:  Rong Wang; Barbara C McGrath; Richard F Kopp; Michael W Roe; Xin Tang; Gong Chen; Douglas R Cavener
Journal:  J Biol Chem       Date:  2013-10-10       Impact factor: 5.157

4.  Chronic stimulation induces adaptive potassium channel activity that restores calcium oscillations in pancreatic islets in vitro.

Authors:  Nathan C Law; Isabella Marinelli; Richard Bertram; Kathryn L Corbin; Cara Schildmeyer; Craig S Nunemaker
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-02-18       Impact factor: 4.310

5.  Homozygous mutations in NEUROD1 are responsible for a novel syndrome of permanent neonatal diabetes and neurological abnormalities.

Authors:  Oscar Rubio-Cabezas; Jayne A L Minton; Iren Kantor; Denise Williams; Sian Ellard; Andrew T Hattersley
Journal:  Diabetes       Date:  2010-06-23       Impact factor: 9.461

6.  Fanconi syndrome and neonatal diabetes: phenotypic heterogeneity in patients with GLUT2 defects.

Authors:  Priyanka Khandelwal; Aditi Sinha; Vandana Jain; Jayne Houghton; Pankaj Hari; Arvind Bagga
Journal:  CEN Case Rep       Date:  2017-11-08

7.  Genome Editing of Lineage Determinants in Human Pluripotent Stem Cells Reveals Mechanisms of Pancreatic Development and Diabetes.

Authors:  Zengrong Zhu; Qing V Li; Kihyun Lee; Bess P Rosen; Federico González; Chew-Li Soh; Danwei Huangfu
Journal:  Cell Stem Cell       Date:  2016-04-28       Impact factor: 24.633

8.  Acute ablation of PERK results in ER dysfunctions followed by reduced insulin secretion and cell proliferation.

Authors:  Daorong Feng; Jianwen Wei; Sounak Gupta; Barbara C McGrath; Douglas R Cavener
Journal:  BMC Cell Biol       Date:  2009-09-04       Impact factor: 4.241

9.  Permanent Neonatal Diabetes in a Patient with a KCNJ11/Q52R Mutation Accompanied by Intermittent Hypoglycemia and Liver Failure.

Authors:  Natalie D Shaw; Joseph A Majzoub
Journal:  Int J Pediatr Endocrinol       Date:  2009-10-08

10.  A novel hypomorphic PDX1 mutation responsible for permanent neonatal diabetes with subclinical exocrine deficiency.

Authors:  Marc Nicolino; Kathryn C Claiborn; Valérie Senée; Anne Boland; Doris A Stoffers; Cécile Julier
Journal:  Diabetes       Date:  2009-12-15       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.